Warning: The NCBI web site requires JavaScript to function. more...
Generate a file for use with external citation management software.
Predicting 15-year prostate cancer specific mortality after radical prostatectomy.
Eggener SE, Scardino PT, Walsh PC, Han M, Partin AW, Trock BJ, Feng Z, Wood DP, Eastham JA, Yossepowitch O, Rabah DM, Kattan MW, Yu C, Klein EA, Stephenson AJ.
J Urol. 2011 Mar;185(3):869-75. doi: 10.1016/j.juro.2010.10.057. Epub 2011 Jan 15.
Similar articles
Nomograms for clinically localized prostate cancer. Part I: radical prostatectomy.
Han M, Partin AW.
Semin Urol Oncol. 2002 May;20(2):123-30.
A critical analysis of the interpretation of biochemical failure in surgically treated patients using the American Society for Therapeutic Radiation and Oncology criteria.
Gretzer MB, Trock BJ, Han M, Walsh PC.
J Urol. 2002 Oct;168(4 Pt 1):1419-22. Erratum in: J Urol 2002 Dec;168(6):2558.
Biochemical (prostate specific antigen) recurrence probability following radical prostatectomy for clinically localized prostate cancer.
Han M, Partin AW, Zahurak M, Piantadosi S, Epstein JI, Walsh PC.
J Urol. 2003 Feb;169(2):517-23.
Long-term cancer control of radical prostatectomy in men younger than 50 years of age: update 2003.
Khan MA, Han M, Partin AW, Epstein JI, Walsh PC.
Urology. 2003 Jul;62(1):86-91; discussion 91-2.
An evaluation of the decreasing incidence of positive surgical margins in a large retropubic prostatectomy series.
Han M, Partin AW, Chan DY, Walsh PC.
J Urol. 2004 Jan;171(1):23-6.
Relationship between initial prostate specific antigen level and subsequent prostate cancer detection in a longitudinal screening study.
Antenor JA, Han M, Roehl KA, Nadler RB, Catalona WJ.
J Urol. 2004 Jul;172(1):90-3.
Cancer progression and survival rates following anatomical radical retropubic prostatectomy in 3,478 consecutive patients: long-term results.
Roehl KA, Han M, Ramos CG, Antenor JA, Catalona WJ.
J Urol. 2004 Sep;172(3):910-4.
Preoperative PSA level significantly associated with interval to biochemical progression after radical retropubic prostatectomy.
Gonzalez CM, Roehl KA, Antenor JV, Blunt LW, Han M, Catalona WJ.
Urology. 2004 Oct;64(4):723-8.
Association of hemospermia with prostate cancer.
Han M, Brannigan RE, Antenor JA, Roehl KA, Catalona WJ.
J Urol. 2004 Dec;172(6 Pt 1):2189-92.
Potency, continence and complications in 3,477 consecutive radical retropubic prostatectomies.
Kundu SD, Roehl KA, Eggener SE, Antenor JA, Han M, Catalona WJ.
J Urol. 2004 Dec;172(6 Pt 1):2227-31.
Should an isolated humeral lesion detected during prostate cancer metastatic survey be biopsied?
Kundu SD, Han M, Catalona WJ.
J Urol. 2004 Nov;172(5 Pt 1):1825-6. No abstract available.
Delays in cancer detection using 2 and 4-year screening intervals for prostate cancer screening with initial prostate specific antigen less than 2 ng/ml.
Kundu SD, Grubb RL, Roehl KA, Antenor JA, Han M, Catalona WJ.
J Urol. 2005 Apr;173(4):1116-20.
Contemporary survival results and the role of radiation therapy in patients with node negative seminal vesicle invasion following radical prostatectomy.
Eggener SE, Roehl KA, Smith ND, Antenor JA, Han M, Catalona WJ.
J Urol. 2005 Apr;173(4):1150-5.
The natural history of clinically localized prostate cancer.
Gann PH, Han M.
JAMA. 2005 May 4;293(17):2149-51. No abstract available.
Preoperative PSA and progression-free survival after radical prostatectomy for Stage T1c disease.
Antenor JA, Roehl KA, Eggener SE, Kundu SD, Han M, Catalona WJ.
Urology. 2005 Jul;66(1):156-60.
Salvage radiation therapy for prostate specific antigen progression following radical prostatectomy: 10-year outcome estimates.
Pazona JF, Han M, Hawkins SA, Roehl KA, Catalona WJ.
J Urol. 2005 Oct;174(4 Pt 1):1282-6.
More favorable tumor features and progression-free survival rates in a longitudinal prostate cancer screening study: PSA era and threshold-specific effects.
Jang TL, Han M, Roehl KA, Hawkins SA, Catalona WJ.
Urology. 2006 Feb;67(2):343-8. Epub 2006 Jan 25.
Pathological characteristics of prostate cancer detected through prostate specific antigen based screening.
Loeb S, Gonzalez CM, Roehl KA, Han M, Antenor JA, Yap RL, Catalona WJ.
J Urol. 2006 Mar;175(3 Pt 1):902-6.
Lymphovascular invasion in radical prostatectomy specimens: prediction of adverse pathologic features and biochemical progression.
Loeb S, Roehl KA, Yu X, Antenor JA, Han M, Gashti SN, Yang XJ, Catalona WJ.
Urology. 2006 Jul;68(1):99-103. Epub 2006 Jun 27.
Filters: Manage Filters